相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
Yingying Cong et al.
JOURNAL OF VIROLOGY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Coronavirus Infections-More Than Just the Common Cold
Catharine I. Paules et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens
Jasper Fuk-Woo Chan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)
Jasper Fuk-Woo Chan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy
M. R. Capobianchi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Evaluate severe acute respiratory syndrome coronavirus 2 infectivity by pseudoviral particles
Tao Pu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
Leon Caly et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
撤稿声明: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion (Retraction of Vol 17, Pg 561, 2020)
Xinling Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andreani et al.
MICROBIAL PATHOGENESIS (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Coronaviruses as the cause of respiratory infections
V. M. Corman et al.
INTERNIST (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
Hannah Kleine-Weber et al.
JOURNAL OF VIROLOGY (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9
Tingting Hu et al.
PROTEIN SCIENCE (2017)
Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein
Chung-ke Chang et al.
DRUG DISCOVERY TODAY (2016)
Vaccines for the prevention against the threat of MERS-CoV
Lanying Du et al.
EXPERT REVIEW OF VACCINES (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Animal models for SARS and MERS coronaviruses
Lisa M. Gretebeck et al.
CURRENT OPINION IN VIROLOGY (2015)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes
Mickael Bouvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang et al.
NATURE REVIEWS CARDIOLOGY (2014)
The Coronavirus Nucleocapsid Is a Multifunctional Protein
Ruth McBride et al.
VIRUSES-BASEL (2014)
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
Darryl Falzarano et al.
PLOS PATHOGENS (2014)
Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
Keiji Kuba et al.
CIRCULATION JOURNAL (2013)
Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity
Christopher C. Stobart et al.
JOURNAL OF VIROLOGY (2013)
Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
Lu Lu et al.
MICROBES AND INFECTION (2013)
The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension
Aartjan J. W. Te Velthuis et al.
NUCLEIC ACIDS RESEARCH (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Jose L. Nieto-Torres et al.
VIROLOGY (2011)
Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
Tomoki Yoshikawa et al.
PLOS ONE (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in Golden Syrian hamsters
Elaine W. Lamirande et al.
JOURNAL OF VIROLOGY (2008)
Pathogenetic mechanisms of severe acute respiratory syndrome
Yong Guo et al.
VIRUS RESEARCH (2008)
Animal models and vaccines for SARS-CoV infection
Anjeanette Roberts et al.
VIRUS RESEARCH (2008)
Pathology and pathogenesis of severe acute respiratory syndrome
Jiang Gu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV
Shuetsu Fukushi et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
SARS-associated coronavirus replication in cell lines
M Kaye et al.
EMERGING INFECTIOUS DISEASES (2006)
Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication
EC Mossel et al.
JOURNAL OF VIROLOGY (2005)
The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world
MP Egloff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
N Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
YQ Ding et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
SARS virus infection of cats and ferrets
BEE Martina et al.
NATURE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
D Harmer et al.
FEBS LETTERS (2002)
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells
K Narayanan et al.
JOURNAL OF VIROLOGY (2000)
分享论文
